Menstrual Cycle Symptom Tracking

Overview

This study will provide menstrual cycle symptom information from women over the course of three menstrual cycles to determine whether there are any noticeable physiological changes that can be related to stage of the menstrual cycle or onset of menstruation.

Full Title of Study: “Menstrual Cycle Symptom Tracking Study”

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: September 10, 2021

Interventions

  • Device: Clearblue Connected Ovulation Test System
    • Clearblue Connected Ovulation Test System which is a CE marked device used for tracking the menstrual cycle

Clinical Trial Outcome Measures

Primary Measures

  • Menstrual Cycle Symptoms
    • Time Frame: 3 months
    • The primary objective of this study is to collect information from women on their experience of menstrual cycle symptoms

Participating in This Clinical Trial

Inclusion Criteria

  • Female – Aged 18 years and over – Regular menstrual cycles – Owns a compatible smart phone i.e. iPhones® and AndroidTM phones equipped with Bluetooth® 4.0/BLE – Willing to use their own smartphone for the duration of this study and to download and install the study app – Willing to give informed consent Exclusion Criteria:

  • Currently trying to conceive – Currently or recently pregnant or breastfeeding – Taking any treatment which may affect the menstrual cycle (e.g. contraceptive pill, fertility medications or hormone replacement therapy) – Taking or undergoing any other medical treatment for fertility such as ovulation drugs, artificial insemination and assisted fertility such as In vitro fertilization (IVF) or Intracytoplasmic sperm injection (ICSI) – Has abnormal liver or kidney function – Taking antibiotics containing tetracycline – Taking clomiphene citrate or other ovulation induction drugs

Gender Eligibility: Female

Female only

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • SPD Development Company Limited
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • Sarah Johnson, PhD, Study Director, SPD Development Company

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.